256 related articles for article (PubMed ID: 38200577)
1. Defining type 2 diabetes polygenic risk scores through colocalization and network-based clustering of metabolic trait genetic associations.
Ghatan S; van Rooij J; van Hoek M; Boer CG; Felix JF; Kavousi M; Jaddoe VW; Sijbrands EJG; Medina-Gomez C; Rivadeneira F; Oei L
Genome Med; 2024 Jan; 16(1):10. PubMed ID: 38200577
[TBL] [Abstract][Full Text] [Related]
2. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis.
Udler MS; Kim J; von Grotthuss M; Bonàs-Guarch S; Cole JB; Chiou J; ; Boehnke M; Laakso M; Atzmon G; Glaser B; Mercader JM; Gaulton K; Flannick J; Getz G; Florez JC
PLoS Med; 2018 Sep; 15(9):e1002654. PubMed ID: 30240442
[TBL] [Abstract][Full Text] [Related]
3. High-throughput genetic clustering of type 2 diabetes loci reveals heterogeneous mechanistic pathways of metabolic disease.
Kim H; Westerman KE; Smith K; Chiou J; Cole JB; Majarian T; von Grotthuss M; Kwak SH; Kim J; Mercader JM; Florez JC; Gaulton K; Manning AK; Udler MS
Diabetologia; 2023 Mar; 66(3):495-507. PubMed ID: 36538063
[TBL] [Abstract][Full Text] [Related]
4. Type 2 Diabetes Partitioned Polygenic Scores Associate With Disease Outcomes in 454,193 Individuals Across 13 Cohorts.
DiCorpo D; LeClair J; Cole JB; Sarnowski C; Ahmadizar F; Bielak LF; Blokstra A; Bottinger EP; Chaker L; Chen YI; Chen Y; de Vries PS; Faquih T; Ghanbari M; Gudmundsdottir V; Guo X; Hasbani NR; Ibi D; Ikram MA; Kavousi M; Leonard HL; Leong A; Mercader JM; Morrison AC; Nadkarni GN; Nalls MA; Noordam R; Preuss M; Smith JA; Trompet S; Vissink P; Yao J; Zhao W; Boerwinkle E; Goodarzi MO; Gudnason V; Jukema JW; Kardia SLR; Loos RJF; Liu CT; Manning AK; Mook-Kanamori D; Pankow JS; Picavet HSJ; Sattar N; Simonsick EM; Verschuren WMM; Willems van Dijk K; Florez JC; Rotter JI; Meigs JB; Dupuis J; Udler MS
Diabetes Care; 2022 Mar; 45(3):674-683. PubMed ID: 35085396
[TBL] [Abstract][Full Text] [Related]
5. Candidate loci shared among periodontal disease, diabetes and bone density.
Yu YH; Steffensen B; Ridker PM; Buring JE; Chasman DI
Front Endocrinol (Lausanne); 2022; 13():1016373. PubMed ID: 36778599
[TBL] [Abstract][Full Text] [Related]
6. Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: A population-based cohort study.
Hodgson S; Huang QQ; Sallah N; ; Griffiths CJ; Newman WG; Trembath RC; Wright J; Lumbers RT; Kuchenbaecker K; van Heel DA; Mathur R; Martin HC; Finer S
PLoS Med; 2022 May; 19(5):e1003981. PubMed ID: 35587468
[TBL] [Abstract][Full Text] [Related]
7. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
[TBL] [Abstract][Full Text] [Related]
8. Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci.
Stamou MI; Smith KT; Kim H; Balasubramanian R; Gray KJ; Udler MS
J Clin Endocrinol Metab; 2024 Mar; 109(4):968-977. PubMed ID: 37967238
[TBL] [Abstract][Full Text] [Related]
9. Smoking Status and Type 2 Diabetes, and Cardiovascular Disease: A Comprehensive Analysis of Shared Genetic Etiology and Causal Relationship.
Chi Y; Wang X; Jia J; Huang T
Front Endocrinol (Lausanne); 2022; 13():809445. PubMed ID: 35250867
[TBL] [Abstract][Full Text] [Related]
10. Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians.
Tam CHT; Lim CKP; Luk AOY; Ng ACW; Lee HM; Jiang G; Lau ESH; Fan B; Wan R; Kong APS; Tam WH; Ozaki R; Chow EYK; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JKY; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Hu M; Yu W; Tsui SKW; Huang Y; Lan H; Szeto CC; Tang NLS; Ng MCY; So WY; Tomlinson B; Chan JCN; Ma RCW; ;
Genome Med; 2021 Feb; 13(1):29. PubMed ID: 33608049
[TBL] [Abstract][Full Text] [Related]
11. Contribution of 24 obesity-associated genetic variants to insulin resistance, pancreatic beta-cell function and type 2 diabetes risk in the French population.
Robiou-du-Pont S; Bonnefond A; Yengo L; Vaillant E; Lobbens S; Durand E; Weill J; Lantieri O; Balkau B; Charpentier G; Marre M; Froguel P; Meyre D
Int J Obes (Lond); 2013 Jul; 37(7):980-5. PubMed ID: 23090577
[TBL] [Abstract][Full Text] [Related]
12. Obesity and Kidney Function: A Two-Sample Mendelian Randomization Study.
Kjaergaard AD; Teumer A; Witte DR; Stanzick KJ; Winkler TW; Burgess S; Ellervik C
Clin Chem; 2022 Mar; 68(3):461-472. PubMed ID: 34922334
[TBL] [Abstract][Full Text] [Related]
13. Shared genetic architecture and casual relationship between leptin levels and type 2 diabetes: large-scale cross-trait meta-analysis and Mendelian randomization analysis.
Wang X; Jia J; Huang T
BMJ Open Diabetes Res Care; 2020 Apr; 8(1):. PubMed ID: 32341051
[TBL] [Abstract][Full Text] [Related]
14. Genetic Predisposition to Type 2 Diabetes and Insulin Levels Is Positively Associated With Serum Urate Levels.
Zhu J; Sun L; Yang J; Fan J; Tse LA; Li Y
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2547-e2556. PubMed ID: 33770169
[TBL] [Abstract][Full Text] [Related]
15. Harnessing tissue-specific genetic variation to dissect putative causal pathways between body mass index and cardiometabolic phenotypes.
Leyden GM; Shapland CY; Davey Smith G; Sanderson E; Greenwood MP; Murphy D; Richardson TG
Am J Hum Genet; 2022 Feb; 109(2):240-252. PubMed ID: 35090585
[TBL] [Abstract][Full Text] [Related]
16. Testing the Utility of Polygenic Risk Scores for Type 2 Diabetes and Obesity in Predicting Metabolic Changes in a Prediabetic Population: An Observational Study.
Padilla-Martinez F; Szczerbiński Ł; Citko A; Czajkowski M; Konopka P; Paszko A; Wawrusiewicz-Kurylonek N; Górska M; Kretowski A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555722
[TBL] [Abstract][Full Text] [Related]
17. Genetic evidence for a normal-weight "metabolically obese" phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes.
Yaghootkar H; Scott RA; White CC; Zhang W; Speliotes E; Munroe PB; Ehret GB; Bis JC; Fox CS; Walker M; Borecki IB; Knowles JW; Yerges-Armstrong L; Ohlsson C; Perry JR; Chambers JC; Kooner JS; Franceschini N; Langenberg C; Hivert MF; Dastani Z; Richards JB; Semple RK; Frayling TM
Diabetes; 2014 Dec; 63(12):4369-77. PubMed ID: 25048195
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Signaling, Insulin Resistance, and 2 Diabetes Mellitus: A Mendelian Randomization Study.
Bos MM; Smit RAJ; Trompet S; van Heemst D; Noordam R
J Clin Endocrinol Metab; 2017 Jun; 102(6):1960-1970. PubMed ID: 28323940
[TBL] [Abstract][Full Text] [Related]
19. Association between a polygenic lipodystrophy genetic risk score and diabetes risk in the high prevalence Maltese population.
Zammit M; Agius R; Fava S; Vassallo J; Pace NP
Acta Diabetol; 2024 May; 61(5):555-564. PubMed ID: 38280973
[TBL] [Abstract][Full Text] [Related]
20. Type 2 Diabetes Mellitus and Amyotrophic Lateral Sclerosis: Genetic Overlap, Causality, and Mediation.
Chen H; Zhang J; Wang T; Zhang S; Lai Q; Huang S; Zeng P
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4497-e4508. PubMed ID: 34171091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
